Skip to content

Inflammatory Bowel Disease Registry in Daegu-Gyeongbuk

Observational Study Using Inflammatory Bowel Disease Registry in Daegu-Gyeongbuk, Southeastern Area of Korea

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02193464
Acronym
EPICODE
Enrollment
100
Registered
2014-07-17
Start date
2014-09-30
Completion date
2026-12-31
Last updated
2021-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic Chronic Inflammatory Bowel Disease

Keywords

inflammatory bowel disease, registry, incidence, Korea

Brief summary

The purpose of this study is to investigate the incidence and natural course of inflammatory bowel disease in the southeastern area of Korea.

Interventions

None listed

Sponsors

Yeungnam University Hospital
CollaboratorOTHER
Daegu Catholic University Medical Center
CollaboratorOTHER
DongGuk University
CollaboratorOTHER
Kyungpook National University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of inflammatory bowel disease including Crohn's disease and ulcerative colitis * Followed up for at least 6 months for the correct diagnosis

Exclusion criteria

* Patients who do not live in Daegu-Gyeongbuk province

Design outcomes

Primary

MeasureTime frameDescription
All newly diagnosed casesone yearIn one year, all inflammatory bowel disease including Crohn's disease and ulcerative colitis which is newly diagnosed in Daegu-Gyeongbuk province of Korea is recorded.

Secondary

MeasureTime frameDescription
All operation casesone yearFor one year, all patients who have surgical managements for IBD are counted.

Other

MeasureTime frameDescription
All cases of disease relapseone yearFor one year, all patients who have disease worsening are counted.

Countries

South Korea

Contacts

Primary ContactEun Soo Kim, MD. PhD
dandy813@hanmail.net+82-53-250-7088

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026